1. P531 Efficacy of tofacitinib maintenance therapy for ulcerative colitis in remitting patients vs. patients with clinical response after 8 weeks of induction treatment. (25th January 2019) Authors: Reinisch, W; Osterman, M T; Doherty, G; Marren, A; Woodworth, D A; Lawendy, N; Kwok, K; Maller, E; Su, C Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S378 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P712 Tofacitinib efficacy in patients with moderate to severe ulcerative colitis: Subgroup analyses of OCTAVE Induction 1 and 2 and OCTAVE Sustain by 5-aminosalicylates use. (25th January 2019) Authors: Hanauer, S; Rubin, D T; Gionchetti, P; Su, C; Woodworth, D A; Quirk, D; Salese, L; Wang, W; Marren, A; Lawendy, N; Panaccione, R Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S477 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗